OxPhos in adipose tissue macrophages regulated by BTK enhances their M2-like phenotype and confers a systemic immunometabolic benefit in obesity.
Saved in:
| Title: | OxPhos in adipose tissue macrophages regulated by BTK enhances their M2-like phenotype and confers a systemic immunometabolic benefit in obesity. |
|---|---|
| Authors: | Purvis GSD; Sir William Dunn School of Pathology, University of Oxford, UK.; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.; Division of Cardiovascular Medicine, British Heart Foundation Centre for Research Excellence, John Radcliffe Hospital, University of Oxford, Oxford, UK., Collino M; Dept of Neurosciences 'Rita Levi Montalcini' University of Turin, Turin, IT., van Dam AD; Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK., Einaudi G; Pharmacology Unit, School of Pharmacy, University of Camerino, Camerino, Italy., Ng Y; Division of Cardiovascular Medicine, British Heart Foundation Centre for Research Excellence, John Radcliffe Hospital, University of Oxford, Oxford, UK.; National Institute for Health (NIHR) Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Shanmuganathan M; Division of Cardiovascular Medicine, British Heart Foundation Centre for Research Excellence, John Radcliffe Hospital, University of Oxford, Oxford, UK.; National Institute for Health (NIHR) Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Patel SY; Primary Immunodeficiency Unit, Department of Experimental Medicine, Nuffield Department of Medicine, University of Oxford, NIHR Oxford Biomedical Research Centre, Oxford, UK., Thiemermann C; The William Harvey Research Institute, Queen Mary University of London, London, UK., Channon KM; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.; Division of Cardiovascular Medicine, British Heart Foundation Centre for Research Excellence, John Radcliffe Hospital, University of Oxford, Oxford, UK.; National Institute for Health (NIHR) Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Greaves DR; Sir William Dunn School of Pathology, University of Oxford, UK. |
| Corporate Authors: | Oxford Acute Myocardial Infarction (OxAMI) Study |
| Source: | Diabetes [Diabetes] 2024 Jan 08. Date of Electronic Publication: 2024 Jan 08. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Diabetes Association Country of Publication: United States NLM ID: 0372763 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1939-327X (Electronic) Linking ISSN: 00121797 NLM ISO Abbreviation: Diabetes Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38193882 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: OxPhos in adipose tissue macrophages regulated by BTK enhances their M2-like phenotype and confers a systemic immunometabolic benefit in obesity. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Purvis+GSD%22">Purvis GSD</searchLink>; Sir William Dunn School of Pathology, University of Oxford, UK.; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.; Division of Cardiovascular Medicine, British Heart Foundation Centre for Research Excellence, John Radcliffe Hospital, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Collino+M%22">Collino M</searchLink>; Dept of Neurosciences 'Rita Levi Montalcini' University of Turin, Turin, IT.<br /><searchLink fieldCode="AU" term="%22van+Dam+AD%22">van Dam AD</searchLink>; Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Einaudi+G%22">Einaudi G</searchLink>; Pharmacology Unit, School of Pharmacy, University of Camerino, Camerino, Italy.<br /><searchLink fieldCode="AU" term="%22Ng+Y%22">Ng Y</searchLink>; Division of Cardiovascular Medicine, British Heart Foundation Centre for Research Excellence, John Radcliffe Hospital, University of Oxford, Oxford, UK.; National Institute for Health (NIHR) Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Shanmuganathan+M%22">Shanmuganathan M</searchLink>; Division of Cardiovascular Medicine, British Heart Foundation Centre for Research Excellence, John Radcliffe Hospital, University of Oxford, Oxford, UK.; National Institute for Health (NIHR) Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Patel+SY%22">Patel SY</searchLink>; Primary Immunodeficiency Unit, Department of Experimental Medicine, Nuffield Department of Medicine, University of Oxford, NIHR Oxford Biomedical Research Centre, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Thiemermann+C%22">Thiemermann C</searchLink>; The William Harvey Research Institute, Queen Mary University of London, London, UK.<br /><searchLink fieldCode="AU" term="%22Channon+KM%22">Channon KM</searchLink>; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.; Division of Cardiovascular Medicine, British Heart Foundation Centre for Research Excellence, John Radcliffe Hospital, University of Oxford, Oxford, UK.; National Institute for Health (NIHR) Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Greaves+DR%22">Greaves DR</searchLink>; Sir William Dunn School of Pathology, University of Oxford, UK. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22Oxford+Acute+Myocardial+Infarction+%28OxAMI%29+Study%22">Oxford Acute Myocardial Infarction (OxAMI) Study</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220372763%22">Diabetes</searchLink> [Diabetes] 2024 Jan 08. <i>Date of Electronic Publication: </i>2024 Jan 08. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Diabetes+Association%22">American Diabetes Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0372763 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1939-327X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200121797%22">00121797 </searchLink><i>NLM ISO Abbreviation: </i>Diabetes <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38193882 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.2337/db22-0275 Languages: – Code: eng Text: English Titles: – TitleFull: OxPhos in adipose tissue macrophages regulated by BTK enhances their M2-like phenotype and confers a systemic immunometabolic benefit in obesity. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Purvis GSD – PersonEntity: Name: NameFull: Collino M – PersonEntity: Name: NameFull: van Dam AD – PersonEntity: Name: NameFull: Einaudi G – PersonEntity: Name: NameFull: Ng Y – PersonEntity: Name: NameFull: Shanmuganathan M – PersonEntity: Name: NameFull: Patel SY – PersonEntity: Name: NameFull: Thiemermann C – PersonEntity: Name: NameFull: Channon KM – PersonEntity: Name: NameFull: Greaves DR IsPartOfRelationships: – BibEntity: Dates: – D: 08 M: 01 Text: 2024 Jan 08 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1939-327X Titles: – TitleFull: Diabetes Type: main |
| ResultId | 1 |